Topics: SarcomaMedical OncologyGIST
How do you approach non-surgical patients with GIST who are intolerant to imatinib 400 mg daily and unlikely to tolerate other TKIs?   

Do you reduce the dose to <400 mg daily or employ dosing schedules?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Siri Onclogy and hematology Infusion Service
As we are finding with other TKI's in other diseas...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution